Rosenstock J, Frias J, Jastreboff AM et al (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Based on the different molecular structures and PK characteristics of the GLP-1 RAs and the presence of GLP-1 receptors on the sinoatrial node, differential effects on HR may be expected
The provider may increase it gradually based on the approved schedule, your response, and your side effects
Always follow the dosing schedule and instructions specific to your prescription
Yes, both of our GLP-1 weight loss medications are real prescription medications that are prescribed by a doctor and compounded by a real US based pharmacy